DISC1 — Disrupted in Schizophrenia 1

DISC1 — Disrupted in Schizophrenia 1

Pathway Diagram

```mermaid
flowchart TD
DISC1["DISC1<br/>Disrupted in Schizophrenia 1"]

%% Neurodevelopmental pathways
DISC1 -->|"regulates"| Neurodevelopment["Neurodevelopment<br/>and Neurogenesis"]
Neurodevelopment -->|"disrupted"| Schizophrenia["Schizophrenia"]
Neurodevelopment -->|"disrupted"| Bipolar["Bipolar Disorder"]
Neurodevelopment -->|"disrupted"| Autism["Autism Spectrum<br/>Disorder"]

%% Neurodegeneration pathways
DISC1 -->|"interacts with"| Neurodegeneration["Neurodegeneration<br/>Processes"]
Neurodegeneration --> Alzheimer["Alzheimer's<br/>Disease"]
Neurodegeneration --> Parkinson["Parkinson's<br/>Disease"]
Neurodegeneration --> ALS["Amyotrophic Lateral<br/>Sclerosis"]
Neurodegeneration --> FTD["Frontotemporal<br/>Dementia"]

%% Protective mechanisms
DISC1 -->|"inhibits"| Anxiety["Anxiety<br/>Disorders"]
DISC1 -->|"protective effect"| MS["Multiple<br/>Sclerosis"]

%% Molecular interactions
CAT["Catalase<br/>(CAT)"] -->|"interacts with"| DISC1
DISC1 -->|"regulates"| SynapticFunction["Synaptic Function<br/>and Plasticity"]
SynapticFunction -->|"impaired"| CognitiveDecline["Cognitive<br/>Decline"]

%% Therapeutic implications
DISC1 -->|"therapeutic target"| CardiovascularHealth["Cardiovascular<br/>Health"]
CognitiveDecline --> Dementia["Dementia"]

%% Depression pathway
DISC1 -->|"regulates"| Depression["Depression"]
Depression -->|"contributes to"| Neurodegeneration

%% Styling
styl

DISC1 — Disrupted in Schizophrenia 1

Pathway Diagram

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">DISC1 — Disrupted in Schizophrenia 1</th>
</tr>
<tr> [@kamiya2005]
<td class="label">Symbol</td> [@porteous2011]
<td><strong>DISC1</strong></td> [@lipina2013]
</tr> [@trossbach2016]
<tr>
<td class="label">Full Name</td>
<td>Disrupted in Schizophrenia 1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>1q42.2</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/27185" target="_blank">27185</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000162946" target="_blank">ENSG00000162946</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/605210" target="_blank">605210</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q9NRI5" target="_blank">Q9NRI5</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), Schizophrenia, Bipolar Disorder, Major Depression</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Hippocampus, Cerebral [cortex](/brain-regions/cortex), Cerebellum, Dentate gyrus</td>
</tr>
<tr>
<th class="infobox-subheader" colspan="2">Key Variants</th>
</tr>
<tr>
<td colspan="2" style="font-size:0.85em">t(1;11)(q42;q14.3) translocation<br>Ser704Cys (rs821616)<br>Leu607Phe (rs6675281)<br>rs3738401</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/ali" style="color:#ef9a9a">ALI</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">474 edges</a></td>
</tr>
</table>

DISC1 — Disrupted in Schizophrenia 1

Overview

DISC1 (Disrupted in Schizophrenia 1) is a gene located on chromosome 1q42.2 that encodes a scaffold protein critical for neurodevelopment, synaptic function, and intracellular signaling. Originally identified through a balanced chromosomal translocation t(1;11)(q42;q14.3) in a large Scottish family with high prevalence of psychiatric illness, DISC1 has since been implicated in multiple neuropsychiatric and neurodegenerative conditions including [Alzheimer's disease](/diseases/alzheimers-disease), schizophrenia, bipolar disorder, and major depressive disorder.

> Key takeaway: DISC1 is a multifunctional scaffold protein that orchestrates neuronal migration, synapse formation, and mitochondrial dynamics. Its disruption links neurodevelopmental processes to neurodegeneration through impaired [GSK3β](/genes/gsk3b) regulation and [tau](/proteins/tau) hyperphosphorylation.

Gene Structure and Expression

Genomic Organization

The DISC1 gene spans approximately 414 kb on chromosome 1q42.2, comprising 13 exons that encode multiple splice variants. The canonical transcript produces a 854-amino acid protein, while alternative splicing generates at least 50 transcript variants with tissue-specific expression patterns. The gene's large size makes it susceptible to structural variants and translocation breakpoints.

Brain Expression Pattern

DISC1 is highly expressed throughout the central nervous system with particular enrichment in:

• [Hippocampus](/brain-regions/hippocampus): Robust expression in CA1, CA3, and dentate gyrus granule cells, regions critical for memory formation and vulnerable in [Alzheimer's disease](/diseases/alzheimers-disease)
• Cerebral cortex: Expressed across all cortical layers with highest levels in layers II/III and V
• [Cerebellum](/brain-regions/cerebellum): Strong expression in Purkinje cells and granule cell layer
• Dentate gyrus: Particularly high in adult neurogenic zones, consistent with DISC1's role in adult neurogenesis

Transcriptional Regulation

DISC1 expression is regulated by:

• Neuronal activity: Activity-dependent transcription via [CREB](/genes/creb1) and MEF2 transcription factors
• [FOXO3](/genes/foxo3): Forkhead box protein regulation during stress responses
• Epigenetic mechanisms: [DNA methylation](/entities/dna-methylation) at the DISC1 promoter varies across brain regions and is altered in psychiatric conditions
• MicroRNAs: miR-135 and miR-185 target DISC1 3'UTR, providing post-transcriptional regulation

Function

Scaffold Protein Activities

DISC1 functions as a molecular scaffold, organizing signaling complexes at multiple subcellular locations:

Key Protein Interactions

DISC1 interacts with over 200 proteins, forming a "DISC1 interactome" that includes:

• [NDE1](/genes/nde1)/[NDEL1](/genes/ndel1): Centrosomal migration complex
• PDE4B/PDE4D: cAMP signaling regulation
• [FOXO3](/genes/foxo3): Transcription factor regulation
• [ATF4](/genes/atf4): Stress response pathway
• Girdin/KIAA1377: AKT signaling and neuronal migration
• [GSK3β](/genes/gsk3b): Wnt/β-catenin pathway regulation
• [TNIK](/genes/tnik): Wnt signaling at synapses

Disease Associations

Alzheimer's Disease

DISC1 connects to [Alzheimer's disease](/diseases/alzheimers-disease) pathology through multiple mechanisms:

• [Tau](/proteins/tau) phosphorylation: DISC1 normally inhibits [GSK3β](/genes/gsk3b), a major kinase for [tau](/proteins/tau) phosphorylation. Loss of DISC1 function leads to GSK3β hyperactivation and subsequent [tau hyperphosphorylation](/mechanisms/tau-hyperphosphorylation), a hallmark of AD
• Amyloid processing: DISC1 modulates [APP](/genes/app) processing indirectly through its regulation of GSK3β, which phosphorylates [presenilin-1](/genes/psen1) and affects [γ-secretase](/entities/gamma-secretase) activity
• Neurogenesis impairment: DISC1 disruption impairs adult hippocampal neurogenesis, contributing to cognitive decline characteristic of AD
• Mitochondrial dysfunction: DISC1 mutations cause mitochondrial transport deficits and altered mitochondrial dynamics, contributing to the [mitochondrial dysfunction](/mechanisms/mitochondrial-dysfunction) observed in AD [neurons](/entities/neurons)

Schizophrenia

The original DISC1 translocation was identified in a Scottish pedigree with 34 affected family members. The t(1;11)(q42;q14.3) translocation directly disrupts the DISC1 coding region and confers:

• ~50-fold increased risk for schizophrenia in translocation carriers
• Additional risks for bipolar disorder, major depression, and adolescent conduct disorder
• Common DISC1 variants (Ser704Cys, Leu607Phe) show modest associations in population studies

Parkinson's Disease

Emerging evidence links DISC1 to [Parkinson's disease](/diseases/parkinsons-disease) through:

• Regulation of mitochondrial dynamics via Miro/TRAK interactions, overlapping with [PINK1](/genes/pink1)/[Parkin](/genes/prkn) pathways
• Modulation of dopaminergic neuron development and survival
• Interaction with [α-synuclein](/proteins/alpha-synuclein) aggregation pathways through GSK3β regulation

Expression

Brain Region Specificity

DISC1 shows highest expression in brain regions most vulnerable to neurodegeneration:

| Brain Region | Expression Level | Relevance |
|---|---|---|
| Hippocampus (CA1) | Very high | Memory, AD vulnerability |
| Prefrontal cortex | High | Executive function, schizophrenia |
| Dentate gyrus | High | Adult neurogenesis |
| Cerebellum | Moderate-high | Motor coordination |
| [Substantia nigra](/brain-regions/substantia-nigra) | Moderate | Dopaminergic neurons, PD |
| Amygdala | Moderate | Emotional processing |

Developmental Expression

DISC1 expression peaks during:

• Embryonic cortical development (E12-E18 in mouse): Neuronal migration and axon guidance
• Postnatal synaptogenesis (P7-P21 in mouse): Synapse formation and maturation
• Adult neurogenic niches: Sustained expression in hippocampal and subventricular zone progenitors

Animal Models

DISC1 Mouse Models

Multiple mouse models have provided insights into DISC1 function:

Key Findings from Models

• DISC1 disruption causes progressive loss of hippocampal volume with aging
• GSK3β hyperactivation in DISC1 mutant mice leads to increased [phospho-tau](/mechanisms/tau-hyperphosphorylation) in hippocampal neurons
• DISC1 mutations impair mitochondrial trafficking in cortical neurons
• Environmental stress (e.g., prenatal immune activation) synergizes with DISC1 variants to produce neurodegenerative phenotypes

Therapeutic Implications

Drug Targets in the DISC1 Pathway

• GSK3β inhibitors: Lithium and selective GSK3β inhibitors rescue some DISC1-related phenotypes in animal models
• PDE4 inhibitors: Rolipram and other PDE4 inhibitors compensate for DISC1-PDE4 interaction loss
• cAMP modulators: Targeting the cAMP/PKA pathway downstream of DISC1 disruption
• Wnt pathway agonists: Restoring Wnt/β-catenin signaling in DISC1-deficient neurons

Clinical Relevance

• DISC1 pathway components are being explored as biomarkers for psychiatric risk stratification
• DISC1-interacting proteins (PDE4, GSK3β) are already targets of approved drugs (lithium, roflumilast)
• Gene-environment interaction studies suggest DISC1 risk variants require environmental triggers, opening prevention strategies

See Also

• [GSK3B](/genes/gsk3b) — Key kinase regulated by DISC1
• [Tau Hyperphosphorylation](/mechanisms/tau-hyperphosphorylation) — Downstream consequence of DISC1 disruption
• [PINK1](/genes/pink1) — Mitochondrial pathway overlap
• [Adult Neurogenesis](investment/adult-neurogenesis) — Process regulated by DISC1
• [Alzheimer's Disease](/diseases/alzheimers-disease) — Major disease association

External Links

• [DISC1 at NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/27185)
• [DISC1 at UniProt (Q9NRI5)](https://www.uniprot.org/uniprot/Q9NRI5)
• [DISC1 at OMIM (605210)](https://omim.org/entry/605210)
• [DISC1 at GeneCards](https://www.genecards.org/cgi-bin/carddisp.pl?gene=DISC1)
• [Allen Brain Atlas — DISC1](https://human.brain-map.org/microarray/search/show?search_term=DISC1)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving DISC1 — Disrupted in Schizophrenia 1 discovered through SciDEX knowledge graph analysis: